Screening with a shell vial assay for antiviral activity against cytomegalovirus
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (1), 5-8
- https://doi.org/10.1016/0732-8893(89)90036-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDSJournal of Medical Virology, 1987
- In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovirDiagnostic Microbiology and Infectious Disease, 1987
- Acyclic guanosine analogs as inhibitors of human cytomegalovirusAntimicrobial Agents and Chemotherapy, 1987
- Sensitivity of Clinical Isolates of Human Cytomegalovirus to 9-(1,3-Dihydroxy-2-Prop.oxymethyl)GuanineThe Journal of Infectious Diseases, 1985
- AMINO (HYDROXYETHOXYMETHYL) PURINE: A NEW WELL-ABSORBED PRODRUG OF ACYCLOVIRThe Lancet, 1984